Shirin Peters, MD
Internal Medicine · New York, NYNPI 1588960389
Payments from drug & device makers
Across 43 payments — averaging $423.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$17K
- Myriad Women's Health, Inc.$300
- AbbVie$265
- Astellas Pharma US Inc$228
- Medtronic$219
- Gilead$140
- plus $552 from 14 others
What the payments were for
- Food & beverage$1,704100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 1 | $16,519 |
| Myriad Women's Health, Inc. | 1 | $300 |
| AbbVie(2 entities) | 5 | $265 |
| Astellas Pharma US Inc | 6 | $228 |
| Medtronic | 2 | $219 |
| Gilead | 6 | $140 |
| Novo Nordisk | 3 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $63 |
| Boehringer Ingelheim | 3 | $62 |
| Sanofi-aventis U.S. LLC | 2 | $53 |
| Viiv Healthcare Company | 2 | $51 |
| Intra-sana Laboratories | 1 | $50 |
| Hologic Sales And Service, LLC | 1 | $36 |
| Philips North America LLC | 1 | $28 |
| Coopersurgical, Inc. | 1 | $28 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $25 |
| Lilly USA, LLC | 1 | $21 |
| Amgen | 1 | $20 |
| Halozyme Inc | 1 | $20 |
| Antares Pharma, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,223 in reported general payments places this provider in the 95th percentile of 9,771 internal medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in New York
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- Sally LauNew York$8.4M
- Maria RubinsteinNew York$6.3M
- Dana RathkopfNew York$6M
- Eytan SteinNew York$5.8M
- James GreenwaldNew York$4.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.